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Abstract 
Background 
Studies indicate that asymptomatic infections do indeed occur frequently for both seasonal 
and pandemic influenza, accounting for about one-third of influenza infections. Studies 
carried out during the 2009 pH1N1 pandemic have found significant antibody response 
against seasonal H1N1 and H3N2 vaccine strains in schoolchildren receiving only pandemic 
H1N1 monovalent vaccine, yet reported either no symptoms or only mild symptoms. 
Methods 
Serum samples of 255 schoolchildren, who had not received vaccination and had pre-season 
HI Ab serotiters <40, were collected from urban, rural areas and an isolated island in Taiwan 
during the 2005–2006 influenza season. Their hemagglutination inhibition antibody (HI Ab) 
serotiters against the 2005 A/New Caledonia/20/99 (H1N1) vaccine strain at pre-season and 
post-season were measured to determine the symptoms with the highest correlation with 
infection, as defined by 4-fold rise in HI titer. We estimate the asymptomatic ratio, or the 
proportion of asymptomatic infections, for schoolchildren during the 2005–6 influenza 
season when this vaccine strain was found to be antigenically related to the circulating H1N1 
strain. 
Results 
Fever has the highest correlation with the 2005–06 seasonal influenza A(H1N1) infection, 
followed by headache, cough, vomiting, and sore throat. Asymptomatic ratio for the 
schoolchildren is found to range between 55.6% (95% CI: 44.7-66.4)-77.9% (68.8-87.0) 
using different sets of predictive symptoms. Moreover, the asymptomatic ratio was 66.9% 
(56.6-77.2) when using US-CDC criterion of fever + (cough/sore throat), and 73.0 (63.3-
82.8) when under Taiwan CDC definition of Fever + (cough or sore throat or nose) + ( 
headache or pain or fatigue). 
Conclusions 
Asymptomatic ratio for children is found to be substantially higher than that of the general 
population in literature. In providing reasonable quantification of the asymptomatic infected 
children spreading pathogens to others in a seasonal epidemic or a pandemic, our estimates of 
symptomatic ratio of infected children has important clinical and public health implications. 
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Background 
Influenza is one of the most common upper respiratory infectious diseases in humans, 
especially in children, although it is generally known that influenza accounts for only a 
proportion of the disease burden caused by respiratory virus, as respiratory syncytial virus 
(RSV) and para-influenza, account for a substantial proportion of these infections. 
Schoolchildren form an important community-based influenza epidemic sentinel group 
because influenza is a common disease among children. Studies have reported attack rates of 
28-43% among school-aged children [1]. 
Children have also been found to shed virus earlier, for up to six days before the illness 
begins, and for a longer time period once they are infected [2-6]. However, among these 
reports, few studies used serological and community-based study design to evaluate the 
impact of influenza virus infection on schoolchildren. It is widely believed that asymptomatic 
cases and asymptomatic infections do occur regularly in both seasonal and pandemic 
influenza and is an important aspect of the epidemiology of influenza, including the past 
2009 pandemic H1N1 influenza (pH1N1) [7]. Hence it was often modeled accordingly in 
many modeling studies [8-11] and shown to possibly impact the validity of the results. 
Moreover, the asymptomatic ratio (or frequency of asymptomatic infection) is also a critical 
parameter for public health purpose of interventions involving contact tracing. Epidemiologic 
studies also suggest that the natural history of influenza virus infection might differ for 
children (or for elderly), although no such data exist [6]. Moreover, some studies have shown 
that schoolchildren may play an important role in household transmissions (e.g., [12-14]). 
However, a recent study on age-specific timing of laboratory-confirmed influenza infections 
using laboratory-confirmed data from Canadian communities has cast doubt on the 
hypothesis that younger school-age children actually lead influenza epidemic waves [15]. 
Furthermore, a recent community-based household study [16] in central Taiwan on antibody 
response against seasonal H1N1 and H3N2 vaccine strains in schoolchildren receiving only 
pH1N1 monovalent vaccine revealed seroconversion rate of 32.8% to seasonal H3N2 vaccine 
strains, suggesting that the wild-type influenza virus, especially H3N2, might have co-
circulated in the community, as co-circulation of the 2009 pH1N1 and seasonal strains had 
also been reported elsewhere [17]. More importantly, the results on the seroconversion rate of 
H3N2 vaccine strain observed in schoolchildren not receiving TIV and had few clinical 
symptoms raise the question that children might acquire asymptomatic or subclinical 
infection, and perhaps play a significant role as the major disseminators in the spread of 
seasonal influenza [18,19]. 
Moreover, in a related study in Taiwan [20] serological evidence indicates significant 
seroconversion of antibodies to the pH1N1 virus with an HI titre of 1:40 by September–
October in 2009 among 306 schoolchildren tested, further highlighting the importance of 
children as asymptomatic transmitters of influenza in households. 
The focus of this paper is to determine which symptoms are the most effective clinical 
predictors of influenza and the asymptomatic ratios of human influenza viruses in 
schoolchildren populations in Taiwan using seasonal influenza sero-epidemiologic data of 
schoolchildren in Taiwan of 2005–2006 winter influenza season, in order to understand 
asymptomatic influenza infection among schoolchildren. 
Influenza infectious symptoms are usually associated with fever, headache, cough, sore 
throat, running nose, myalgia, malaise, and rhinitis. Infected children can also display signs 
of otitis media, nausea and vomiting. However, studies reporting on proportion of 
seroconversion cases that had symptoms vary widely in their definition of symptoms or 
clinical predictors (see, e.g., [6,21-24]). The US Centers for Disease Control and Prevention 
(US CDC) website list of flu symptoms include: fever, cough, sore throat, runny or stuffy 
nose, muscle or body aches, headaches, fatigue (tiredness), vomiting, and diarrhea [25]. In 
this study, we will include fever, sore throat, cough, headache, vomiting, running nose, and 
stomach upset, as the clinical symptoms for influenza in schoolchildren. 
Methods 
Data 
The study period is the 2005–2006 winter flu season from epidemiological-week (e-week) 
50, 2005 to e-week 16, 2006. 1711 study participants were recruited with parental consent 
from primary schools in four different geographical areas in Taiwan, namely, Taipei City, 
Changhua, Ilan, and Kinmen Island. One school was chosen from each area, with the 
exception of Kinmen which had two schools chosen. Most participants were grade 3–5 
primary school students, except in one school in Kinmen where students from grade 1–6 were 
recruited, due to its small sample size. The four areas were chosen owing to their different 
risk levels for influenza. Taipei City is a metropolis of high-density population with many 
foreign immigrants and visitors, and hence influenza viruses could be transmitted easily; 
Kinmen is an off-shore island with frequent traffic to and from the nearby Chinese mainland; 
Ilan is a suburban county; and Changhua County is a rural area. 
Paired serum samples were collected from the students twice, before and after the 2005–2006 
influenza season during November 2005 and April 2006, respectively, with the signed 
informed consent from the student’s parents or guardians. Factors relating to risk or 
protection factors and demographic information were obtained through questionnaire filled 
out by student’s parents or guardians, which was collected along with the signed informed 
consent for the after-season sampling. In addition, questionnaires on influenza-like clinical 
symptoms (i.e., fever, sore throat, cough, headache, vomiting, running nose, and stomach 
upset) and whether the children had received influenza vaccination during the study period 
were collected at the second after-season sampling time. 1062 children remained for the 
complete study period. The study protocol was approved by the Ethics Committee of the 
Taipei Hospital. For details of the sampling study and of the study participants, see [26,27]. 
Each serum specimen contained 3-5 ml of whole blood collected in serum tube and 
centrifuged at 1,200 rpm/ 10 mins, 4°C within 24 hours to separate RBC and serum. The 
serum samples were stored at −20°C. Serum samples were treated by RDE (Cambrex) to 
remove non-specific inhibitors in serum before Haemagglutination-Inhibition (HI) test. 
Seroconversion is defined as ≧4-fold rise in hemagglutination inhibition antibody (HI Ab) 
serotiter [28]. Seroprotection is defined as the HI titer ≧40. We compute the geometric mean 
titer (GMT) of a group of subjects when data analysis is needed to compare the antibody 
levels between different groups, and a HI titer of less than 10 is assigned a value of 5 for the 
computation of GMT. The virus strains selected in this study were three human influenza 
virus vaccine-like strains recommend by the World Health Organization (WHO) in 2005; 
namely, A/New Caledonia/20/99 (H1N1), A/California/7/2004 (H3N2) and 
B/ShangHI/361/2002. All vaccine strains were derived from the Taiwan Center for Disease 
Control and Prevention (TCDC) and grew in Madin-Darby Canine Kidney (MDCK) cells for 
two passages. 
A total of 586 children who had not been vaccinated for influenza in the last 12 months prior 
to the start of the study are included for this current study. To avoid the confounding effects 
of existing pre-immunity on seroconversion of the schoolchildren, we only include those 
children with pre-season HI titer < 40, which totals 255. Demographic characteristics and 
GMTs of these 255 children are given in Table 1. The seroconversion rate of influenza 
infection (≧4-fold rise in HI titer) among these 255 schoolchildren for the 3 above-mentioned 
vaccine strains is given in Table 2. 
Table 1 Demographic characteristics and geometric mean serotiters 
Characteristics  KM CH TP IL Total 
n (%) n (%) n (%) n (%) n (%) 
Cohort size  71 (27.84) 60 (23.53) 43 (16.86) 81 (31.76) 255 
Gender male 31 (43.66) 36 (60.00) 16 (37.21) 41 (50.62) 124 (48.63) 
female 38 (53.52) 24 (40.00) 22 (51.16) 40 (49.38) 124 (48.63) 
missing 2 (2.82) 0 (0.00) 5 (11.63) 0 (0.00) 7 (2.75) 
Grade 1-3 23 (32.39) 29 (48.33) 19 (44.19) 30 (37.04) 101 (39.61) 
4-6 48 (67.61) 31 (51.67) 24 (55.81) 50 (61.73) 153 (60.00) 
missing 0 (0.00) 0 (0.00) 0 (0.00) 1 (1.23) 1 (0.39) 
GMT (pre-season)  16.94 13.82 13.58 11.57 13.78 
GMT (post-season)  41.59 19.32 21.76 25.41 26.67 
255 unvaccinated schoolchildren from Taipei City (TP), Changhua (CH), Ilan (IL), and Kinmen (KM) participated in the study. 
Table 2 Summary table for pathogen-specific seroconversion rates (≧4-fold rise in HI serotiter) of the 255 schoolchildren 
Vaccine strain Seroconversion number (%) 
A/New Caledonia/20/99 (H1N1) 80 (31.37) 
A/California/7/2004 (H3N2) 31 (12.17) 
B/Shanghai/361/2002 (B) 4 (1.57) 
Moreover, it has been reported that, for 2005–2006, of the three vaccine strains only A/New 
Caledonia/20/99 (H1N1) vaccine strain is found to be antigenically related to the circulating 
strain in Taiwan [29]. Since the serotesting in this study were carried out with the vaccine 
strain only, we will focus our study on the seroprotection and seroconversion of A/New 
Caledonia/20/99 (H1N1) of the 255 unvaccinated children with pre-season HI titer < 40 for 
H1N1. 
Statistical method 
First we utilize the logistic regression model to distinguish the most important symptoms of 
influenza infection by fitting a logistic regression model to the binary influenza infection 
outcome in the sample, using binary indicators of the influenza-like symptoms as predictors. 
Univariate analysis by Fisher exact test and stepwise logistic regression were used to identify 
the symptoms that influenced the infection during the flu season. The Receiver Operating 
Characteristic (ROC) curve is used to examine the performance of logistic regression model. 
We start with a comprehensive model that includes most conceivable and testable factors of 
an influenza infection. We then exclude covariates with p-values exceeding 0.5. Those 
covariates with high p-values indicate that they probably contribute more noise than 
predictive information to the model. Lastly, we implemented the stepwise method for 
selecting the best possible submodel. Relevant statistical details are given in the Appendix. 
The second part of our analysis involves estimating the asymptomatic ratio based on our 
earlier findings of the most predictive clinical symptoms for influenza infection. We then 
compute the asymptomatic infection ratios and 95% confidence intervals under these sets of 
symptoms and investigate the asymptomatic infection ratios with stratified data. 
Results 
Symptoms of influenza infection 
A total of 124 of the 1062 children who completed the study reported to have had some 
symptoms between two samplings. Moreover, 80 children were determined to have 
seroconverted for A/New Caledonia/20/99 (H1N1), for whom the outcome of univariate 
analysis of all binary influenza-like symptoms is shown in Table 3, indicating four factors 
(fever, sore throat, headache, and vomiting) have statistically significant effects on the 
influenza infection. 
Table 3 Univariate Analysis of influenza-like symptoms for H1N1 (n = 255) 
Symptom H1N1 Seroconversion n = 80 (%) Tested Negative for H1N1 n = 159 (%) P-value 
Fever 53 (66.3%) 36 (22.6%) <.0001* 
Sore Throat 37 (56.9%) 48 (36.9%) .0094* 
Cough 59 (83.1%) 104 (72.7%) .1246 
Headache 31 (50.8%) 26 (21.3%) <.0001* 
Vomiting 17 (32.1%) 11 (9.9%) .0007* 
Running Nose 55 (82.1%) 113 (80.7%) .8520 
Stomach upset 10 (20.0%) 11 (9.8%) .0824 
Demographic variables    
Gender   .1657 
      Male 34 (43.0%) 82 (53.6%)  
      Female 45 (57.0%) 71 (46.4%)  
Grade   .0172 
      Low (1–3) 39 (48.8%) 52 (32.7%)  
      High(4–6) 41 (51.3%) 107 (67.3%)  
* denotes statistically significant at 5% level. 
Stepwise multivariate logistic regression analysis is then applied to developing the prediction 
model. An analysis of multivariate logistic regression, with odds ratio (OR) and 95% 
confidence interval (CI), is shown in Tables 4 and 5. Clinical symptoms that are significant 
predictive indicators for influenza infection (Table 4a) include the fever (OR =5.20, 95% CI: 
2.30-12.20) and headache (OR = 4.38, 95% CI: 1.36-15.18). Predictive symptoms for 
influenza infection, with gender and grade added (Table 5b), include the fever (OR = 3.92, 
95%CI: 1.67-9.40), headache (OR = 4.90, 95% CI: 1.44-18.05), and vomiting (OR = 5.77, 
95% CI: 1.07-36.67). 
Table 4 Multivariate Logistic Regression Analysis for H1N1 
Symptom OR (95% CI) P-value 
Fever 5.20 (2.30-12.20) <0.0001* 
Sore throat 1.58 (0.59-4.14) 0.353 
Cough 2.33 (0.87-6.96) 0.107 
Headache 4.38 (1.36-15.18) 0.015* 
Vomiting 5.59 (0.98-37.88) 0.060 
Running nose 1.09 (0.41-3.06) 0.862 
Stomach upset 1.20 (0.09-11.73) 0.881 
* denotes statistically significant at 5% level. 
Table 5 Multivariate Logistic Regression Analysis for H1N1 with gender and grade 
Variables OR (95% CI) P-value 
Fever 3.92 (1.67-9.40) 0.0018* 
Sore throat 1.86 (0.68-5.00) 0.2167 
Cough 2.25 (0.82-6.86) 0.1309 
Headache 4.90 (1.44-18.05) 0.0128* 
Vomiting 5.77 (1.07-36.67) 0.0467* 
Running nose 0.93 (0.34-2.66) 0.8891 
Stomach upset 0.84 (0.07-8.15) 0.8852 
Gender (M) 0.66 (0.28-1.55) 0.3420 
Grade (H) 0.46 (0.18-1.10) 0.0841 
* denotes statistically significant at 5% level. 
The most useful prognostic variables for the logistic regression model with a threshold 
probability of 0.5 are used to predict the patients who are likely to have been infected. Table 
6 shows the sensitivity and specificity analyses to assess the prediction power of logistic 
regression models. In addition, there are other commonly used measures of the performance 
measures of a prediction model, namely, positive predictive value (PPV), defined as the 
proportion of patients with predicted infection who are correctly predicted, and negative 
predictive value (NPV), defined as the proportion of patients with predicted non-infection 
who are correctly predicted. The last two models, denoted by models (1) and (2) in Table 6, 
appear to be the best models of symptom predictors for influenza infection. 
Table 6 Multivariate Predictors of Influenza Infection with PPV, NPV, Sensitivity, and Specificity Analyses with 95% confidence 
intervals (in parenthesis) 
Symptom PPV NPV Sensitivity Specificity 
Fever 59.6 (51.5-67.1) 82.0 (76.8-86.2) 66.3 (54.8-76.5) 77.4 (70.1-83.6) 
Fever + headache 77.4 (61.0-88.3) 75.7 (71.7-79.3) 39.3 (27.1-52.7) 94.3 (88.5-97.7) 
Fever + headache + cough 77.8 (59.9-89.1) 75.7 (71.8-79.2) 36.8 (24.4-50.7) 94.9 (89.3-98.1) 
Fever + headache + throat 75.0 (60.2-85.6) 79.0 (74.4-82.9) 48.2 (34.7-62.0) 92.4 (86.0-96.5) 
Fever + headache + vomiting (model 1) 90.5 (69.7-97.5) 77.9 (73.6-81.6) 39.6 (25.8-54.7) 98.1 (93.2-99.8) 
Fever + headache + vomiting + grade (model 2) 67.4 (55.3-77.5) 84.0 (78.0-88.5) 64.6 (49.5-77.8) 85.6 (77.3-91.7) 
Figure 1 presents a plot of the logistic model of influenza infection as predicted by the four 
statistically significant symptoms. The fitted probabilities of infection are sorted by 
probability so that the less probable infections are located to the left and the most probable 
infections are to the right. The patients were observed either as infection (coding as 1) at the 
top or no infection (coding as 0) at the bottom. The red ticks represent errors; either false 
positives or false negatives. Clearly, more false negatives lead to lower sensitivity, whereas 
less false positives lead to higher specificity. The line of fitted probability is away from the 
threshold of 0.5, shown as a horizontal dash line. In particular, some patients clustered to the 
right and to the left are predicted very well. There is a clear difference between symptoms of 
those with infection and those without. 
Figure 1 Logistic model of H1N1 influenza infection predicted by fever, headache, 
vomiting, and grade. 
The ROC curve shown in Figure 2 is a plot of the sensitivity of the model prediction against 
the complement of its specificity at a series of thresholds for a positive outcome to help 
visualize prediction performance. The further apart is the curve from the diagonal, the more 
accurate the model is. The area under the ROC curve (AUC) provides an overall measure of 
classification accuracy of the model, with the value of one representing perfect accuracy. The 
ROC curve shows a moderate ability to discriminate influenza infection with AUC = 0.75. 
Figure 2 ROC curves of two logistic models (1) and (2) for influenza infection 
prediction, where the model (1) is a three-variable model based on predictors (fever, 
headache, and vomiting) and the model (2) is a four-variable model with the grade 
added to the model (1). 
Stratification analysis of influenza infection by age 
The total children are stratified by the grades for the logistic regression analysis. The children 
students are divided into younger children with grade 1–3 and older children with grade 4–6. 
Table 7 shows the outcomes of a univariate analysis of factors associated with influenza 
infection according to the stratification criterion. Fever is the most significant risk factor in 
both groups. Fever (p < 0.0001), cough (p = 0.261), headache (p = 0.018), and vomiting (p = 
0.0341) are significant risk factors for the younger schoolchildren; whereas in the older 
group, fever (p < 0.0001), sore throat (p-value = 0.0125), headache (p-value = 0.010), and 
vomiting (p = 0.0191) are significant. 
Table 7 Univariate Analysis of Influenza-like Symptoms for Grade Stratification 
Symptom Seroconversion for Influenza Tested Negative for Influenza P-value 
Grades 1-3 n = 39 n = 52  
Fever 29 (74.4%) 17 (32.7%) <.0001 
Sore Throat 16 (48.5%) 14 (33.3%) .2370 
Cough 31 (86.1%) 30 (63.8%) .0261* 
Headache 16 (48.5%) 6 (13.6%) .0018* 
Vomiting 9 (31.0%) 4 (10.0%) .0341* 
Running Nose 23 (76.7%) 41 (87.2%) .3497 
Stomach upset 4 (15.4%) 3 (7.7%) .4240 
Grades 4-6 n = 41 n = 107  
Fever 24 (58.5%) 19 (17.8%) <.0001* 
Sore Throat 21 (65.6%) 34 (38.6%) .0125* 
Cough 28 (80.0%) 74 (77.1%) .8152 
Headache 15 (53.6%) 20 (25.6%) .0100* 
Vomiting 8 (33.3%) 7 (9.9%) .0191* 
Running Nose 32 (86.5%) 72 (77.4%) .3327 
Stomach upset 6 (25.0%) 8 (11.0%) .1033 
* denotes statistically significant at 5% level. 
In the stepwise logistic regression model, the only risk factor that are significantly associated 
with influenza infection is cough (OR = 4.62, 95% CI: 1.05-65.83) in the grade 1–3 group 
while in the grade 4–6 group only fever is significant (OR = 4.05, 95% CI: 1.20-13.94), as 
shown in Table 8. 
Table 8 Multivariate Logistic Regression Analysis for Schoolchildren stratified age/grade 
Age/Grade Symptom OR (95% CI) P-value 
1-3 Fever 2.61 (0.68-10.05) .1628 
 Sore throat 0.90 (0.15-4.47) .8945 
 Cough 4.62 (1.05-65.83) .0464* 
 Headache 19.78 (0.77-509.94) .0718 
 Vomiting 8.12 (0.53-589.51) .1615 
 Running nose 0.45 (0.06-2.04) .3157 
 Stomach upset 0.45 (0.004-7.74) .6383 
4-6 Fever 4.05 (1.20-13.94) .0237* 
 Sore throat 2.67 (0.74-9.55) .1280 
 Cough 1.37 (0.35-6.00) .6592 
 Headache 2.88 (0.66-12.83) .1551 
 Vomiting 4.30 (0.44-52.00) .2152 
 Running nose 1.85 (0.48-8.36) .3894 
 Stomach upset 1.64 (0.04-85.14) .7934 
* denotes statistically significant at 5% level. 
In Table 9, we compare the results of applying different combinations of risk factors to the 
younger and elder groups. That is, we compare PPV, NPV, Sensitivity, and Specificity using 
two significant risk factors in younger group with using one significant risk factor in elder 
group. The latter outperforms the former in terms of sensitivity and specificity. Overall, both 
models reveal high specificity and low sensitivity. However, this difference is possibly due to 
a proportion of asymptomatic infection. The plots of the logistic model and the ROC curves 
for Tables 8, 9 are given in Figures 3, 4. 
Table 9 Multivariate Predictors of Influenza Infection 
Grade Symptom PPV NPV Sensitivity Specificity 
1-3 Fever 63.0 (52.6-72.4) 77.8 (66.5-86.1) 74.4 (57.9-87.0) 67.3 (52.9-79.7) 
 Fever + cough 67.7 (54.1-78.8) 73.5 (63.6-81.5) 63.9 (46.2-79.2) 76.6 (62.0-87.7) 
 Fever + headache 72.7 (53.9-85.9) 69.1 (61.1-76.1) 48.5 (30.8-66.5) 86.4 (72.6-94.8) 
 Fever + vomiting 63.6 (50.9-74.7) 77.8 (65.2-86.7) 72.4 (52.8-87.3) 70.0 (53.5-83.4) 
 Fever + cough + vomiting 69.0 (54.4-80.6) 76.9 (65.4-85.5) 69.0 (49.2-84.7) 76.9 (60.7-88.9) 
 Fever + cough + headache 63.9 (51.8-74.5) 79.0 (66.7-87.5) 74.2 (55.4-88.1) 69.8 (53.9-82.8) 
 Fever + cough + vomiting + headache 70.4 (55.1-82.1) 81.1 (69.0-89.2) 73.1 (52.2-88.4) 79.0 (62.7-90.4) 
 Fever + cough + vomiting + sore throat 66.7 (52.8-78.2) 77.8 (65.4-86.6) 71.4 (51.3-86.8) 73.7 (56.9-86.6) 
4-6 Fever 55.8 (43.8-67.2) 83.8 (78.1-88.3) 58.5 (42.1-73.7) 82.3 (73.7-89.0) 
 Fever + cough 53.6 (38.0-68.5) 80.6 (75.5-84.8) 42.9 (76.3-60.6) 86.5 (78.0-92.6) 
 Fever + headache 73.3 (48.8-88.8) 81.3 (76.3-85.5) 39.3 (21.5-59.4) 94.9 (87.4-98.6) 
 Fever + vomiting 85.7 (43.2-97.9) 79.6 (75.5-83.1) 25.0 (9.8-46.7) 98.6 (92.4-100) 
 Fever + headache + vomiting 83.3 (54.2-95.5) 84.2 (78.4-88.7) 45.5 (24.4-67.8) 97.0 (89.5-99.6) 
 Fever + headache + sore throat 79.0 (57.8-91.1) 86.8 (80.6-91.1) 57.7 (36.9-76.6) 94.7 (87.1-98.5) 
PPV, NPV, Sensitivity, and Specificity Analyses for Schoolchildren are stratified by grade with 95% confidence intervals (in parenthesis). 
Figure 3 (a) Logistic model of H1N1 influenza infection predicted by fever, headache, 
vomiting, and cough for Younger Schoolchildren of grades 1–3. (b) ROC curves of the 
combination of symptoms in last 3 rows of Table 9, denoted respectively by (1), (2), and (3), 
for influenza infection prediction on Younger Schoolchildren of grades 1–3. 
Figure 4 (a) Logistic model of H1N1 influenza infection predicted by fever, headache, 
vomiting, and sore-throat for Older Schoolchildren of grades 4–6. (b) ROC curves of the 
combination of symptoms in last 3 rows of Table 9, denoted respectively by (1), (2), and (3), 
for influenza infection prediction on Older Schoolchildren of grades 4–6. 
Asymptomatic ratio 
We estimate the asymptomatic ratios (Table 10) based on the symptoms (or combination of 
symptoms) with the highest correlation from earlier analysis. We also obtain the 
asymptomatic ratio based on no symptoms, as this criterion is often used in literature [6]. 
Moreover, asymptomatic ratios based on the criteria for influenza-like-illness (ILI) used by 
US-CDC (i.e., fever + (cough or sore throat)), and TCDC (i.e., fever + (cough or sore throat 
or running nose) + ( headache or pain or fatigue)) are also provided. 
Table 10 Asymptomatic ratios (in%) with 95% confidence intervals based on combination of symptoms 
Symptoms Asymptomatic ratio (%) 
Fever 65.1 (54.7-75.6) 
Fever + cough 70.5 (60.6-80.5) 
Fever + (cough or vomiting) 67.2 (56.9-77.5) 
Fever + (cough or headache) 63.8 (53.2-74.3) 
Fever + (cough or nose) 63.9 (53.3-74.4) 
Fever + (cough or vomiting or headache) 61.2 (50.5-71.9) 
Fever + sore throat 77.9 (68.8-87.0) 
Fever + ( sore throat or vomiting) 73.7 (64.1-83.4) 
Fever + ( sore throat or headache) 71.1 (61.1-81.0) 
Fever + ( sore throat or nose) 66.7 (56.3-77.0) 
Fever + ( sore throat or vomiting or headache) 68.9 (58.8-79.1) 
Any symptom 55.6 (44.7-66.4) 
Fever + (cough or sore throat)* 66.9 (56.6-77.2) 
Fever + (cough or sore throat or nose) + (headache or pain or fatigue)# 73.0 (63.3-82.8) 
*denotes US-CDC criteria for ILI; # denotes TCDC criteria for ILI. 
We also consider asymptomatic ratios stratified by location, gender, and age/grade. 
Asymptomatic ratios stratified by the 4 areas are given in Table 11. For all cases, stratified 
asymptomatic ratios in Taipei City are always significantly smaller than that of the other 
locations. The corresponding estimates for the asymptomatic ratios stratified by gender and 
age are not statistically significantly different, and hence the details are omitted here. 
Table 11 Asymptomatic ratios with 95% confidence interval based on combination of symptoms stratified by location: Kinmen (KM), 
Changhua (CH), Ilan (IL), and. Taipei City (TP) 
Symptoms Asymptomatic ratio stratified by area (%) P-value1 
KM CH IL TP 
Fever 64.8 (48.3-81.4) 73.9 (43.5-100) 84.9 (72.2-97.5) 45.2 (12.7-77.8) 0.0033 
Fever + cough 76.5 (61.8-91.2) 76.2 (46.7-100) 87.9 (76.4-99.4) 29.2 (0.0-58.9) <.0001 
Fever + (cough or vomiting) 71.4 (55.8-87.1) 76.2 (46.7-100) 87.9 (76.4-99.4) 10.5 (0.0-30.6) <.0001 
Fever + (cough or headache) 64.6 (48.0-81.2) 76.2 (46.7-100) 87.9 (76.4-99.4) 20.0 (0.0-46.1) <.0001 
Fever + (cough or nose) 66.7 (50.3-83.0) 76.2 (46.7-100) 84.9 (72.2-97.5) 20.0 (0.0-46.1) <.0001 
Fever + (cough or vomiting or headache) 62.5 (45.7-79.3) 76.2 (46.7-100) 87.9 (76.4-99.4) 9.1 (0.0-27.9) <.0001 
Fever + sore throat 82.0 (68.7-95.3) 100.0 (−) 87.9 (76.4-99.4) 22.2 (0.0-49.4) <.0001 
Fever + ( sore throat or vomiting) 75.5 (60.6-90.4) 100.0 (−) 87.9 (76.4-99.4) 0.0 (−) <.0001 
Fever + ( sore throat or headache) 68.8 (52.7-84.8) 100.0 (−) 87.9 (76.4-99.4) 15.8 (0.0-39.6) <.0001 
Fever + ( sore throat or nose) 72.0 (56.4-87.6) 81.0 (53.7-100) 84.9 (72.2-97.5) 13.6 (0.0-36.1) <.0001 
Fever + ( sore throat or vomiting or headache) 66.7 (50.3-83.0) 100.0 (−) 87.9 (76.4-99.4) 0.0 (−) <.0001 
Any symptom 39.1 (22.2-56.0) 65.0 (31.9-98.1) 72.7 (57.1-88.4) 0.0 (−) <.0001 
Fever + (cough or sore throat)* 74.0 (58.8-89.2) 76.2 (46.7-100) 84.9 (72.2-97.5) 17.4 (0.0-42.2) <.0001 
Fever + (cough or sore throat or nose) + ( headache or pain or tired)# 72.9 (57.5-88.3) 90.5 (70.1-100) 90.9 (80.8-100) 0.0 (−) <.0001 
*denotes US-CDC criteria for ILI; # denotes TCDC criteria for ILI. 
1P-value from chi-square test. 
Conclusions and discussions 
The asymptomatic influenza ratio for schoolchildren estimated in this study is found to be 
considerably higher than that of all age groups in previous studies [6]. There are several 
possible explanations. First, there are very few studies in the past that focused on children 
alone and our study indicates that age-specific difference in asymptomatic ratio can be 
significant. Moreover, our community-based study includes children recruited from the 
community where pre-immunity exists, perhaps at a substantial level, which might also lead 
to milder symptoms. However, in this study we have excluded all children with prior 
seroprotection of HI titer greater than or equal 40 to avoid this confounding factor. Finally, 
our study is confined to that of seasonal H1N1 infection. It has been shown in a comparative 
study [26] of pathogen-specific asymptomatic ratio for influenza based on this same data set 
but using having fever or body aches + headache as the criteria for symptoms, that the 
asymptomatic ratio for seasonal H1N1 (75%) is higher than that of seasonal H3N2 (65%), 
perhaps reflecting more frequent infection of H1N1 during past influenza seasons on the 
population-level. Note that in [27], children with high pre-season HI titers were not excluded 
from their analysis which contributes to a higher asymptomatic ratio. 
We note that there has been a significant body of literature on the sensitivity and specificity 
of selected ILI symptoms to actual influenza infection (e.g., [22,24]). In this study, we have 
focused primarily on the logistic regression model, commonly used to analyze medical 
prognostication model. This model has the advantage of easy explanations for the model 
parameters in practice. Although we use a stepwise logistic regression to assist us in 
developing the prediction model in this study, the numerous disadvantages of stepwise 
selection are well known and discussed within statistical literatures. The principal drawbacks 
of stepwise selection include biases in parameter estimation and reported p-value, 
inconsistencies among model selection algorithms, an issue of multiple hypotheses testing, 
and the possibility of missing the optimal model. To overcome these obstacles, we implement 
the stepwise regression in conjunction with considering all possible subsets of the same 
number of factors as in the stepwise solution to examine whether some other subsets of 
factors might be better. In addition, the AIC criterion, the ROC, and clinical knowledge are 
utilized to determine the best possible submodel. We note that some more recently proposed 
regularized regression technique, such as the least-angle regression (LARS-Lasso) algorithm 
[30], might also be useful to identify the set of symptoms most predictive of an influenza 
infection. 
The asymptomatic ratio among schoolchildren in Taipei City, the only urban city in our study 
with markedly higher level of education among parents compared to other rural areas, is 
significantly smaller than that of the other rural locations. No other significant regional 
difference in the respective asymptomatic ratios is observed, perhaps partly due to 
stratification resulting in smaller cohort sizes. The asymptomatic ratios of younger 
schoolchildren of grades 1–3 are slightly higher than those of older children of grades 4–6, 
indicating the various factors such as community setting (urban vs. rural) and age which 
might affect the asymptomatic ratio. 
Children are known to have higher infection rates than adults and high viral transmission with 
clustering cases with higher influenza virus isolation rate often found in children when 
compared with adults. Therefore, schoolchildren are vectors in influenza epidemics. One US 
study indicates that ILI cases increase economic burden among households with school-aged 
children and lead to more school and workdays lost [31]. When vaccinating those at greatest 
risk of mortality becomes impractical (if, e.g., medical care were relatively inaccessible) or 
inefficient (if, e.g., immune responses were deficient), targeting those most likely to expose 
them might be preferable [32]. One study comparing influenza mortality among elderly 
Japanese when children were and were not vaccinated suggests infected children pose a risk 
to others [33], including elderly people, who however also may be infected by intermediates. 
Numerous US experiences (as summarized in [34]) are also consistent with this conclusion, 
although the issue has become somewhat controversial following the recent publication of 
age-specific timing of lab confirmed influenza infections indicating slight age-specific 
differences in the timing of infection [15]. 
The asymptomatic ratio relates to the likely success of public health interventions such as the 
‘stay home if you’re sick’ message. Furthermore, it is important from the perspective of 
public health interventions to clarify the symptoms. For example, the PPV and specificity of 
‘runny nose’ or ‘cough’ in the absence of any other symptoms would be helpful in defining 
an appropriate list of symptoms. While predicting the ultimate success of the intervention is a 
modeling issue, providing an evidence basis and discussion of symptoms as predictors of 
influenza links directly to clarification of the public health message. 
Estimate of the symptomatic ratio of infected children for seasonal H1N1 is important for 
modeling studies aimed to provide reasonable quantification of the impact of asymptomatic 
infective children who may be capable of spreading pathogens to others in a seasonal or 
pandemic epidemic. Ascertainment of the role of children in spread of influenza, including 
asymptomatic infections, and its interventions is of public health importance in post-
pandemic influenza seasons. 
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Appendix 
Statistical details 
Univariate analysis by Fisher exact test and stepwise logistic regression were used to identify 
the symptoms that influenced the influenza infection during the flu season. Logistic 
regression models provide odds-ratio estimations and predicted risk of the infection given a 
set of risk factors, as well as allow adjustment for confounders. (Given a set of risk factors, 
logistic regression analyses, after adjustment for confounders, provide odds ratio estimates 
and predicted risk of infection.) Stepwise multivariate logistic regression analysis was 
performed to identify significant prognostic factors associated with the influenza infection. 
The logistic regression model provides the estimated probability of infection for a particular 
patient with symptom variables {X1, X2,…, Xk}. This probability is equal to y = 1/(1 + e-z), 
where z = β0 + β1 X1 + β2 X2 + … + βk Xk, and e is the base value of natural logarithm. The 
resulting logistic regression model was made based on the forward stepwise model selection 
procedure and after further investigating the two-way interactions between the predictors. 
Receiver operating characteristic (ROC) curves were constructed and the area under an ROC 
curve (AUC, also known as the c-statistic) provides an overall assessment of prediction 
performance. All tests were two-sided, and a p-value of <0.05 are considered to be 
statistically significant. 
References 
1. Neuzil KM, Hohlbein C, Zhu Y: Illness among schoolchildren during influenza season: 
effect on school absenteeism, parental absenteeism from work, and secondary illness in 
families. Arch Pediatr Adolesc Med 2002, 156(10):986–991. 
2. Hall CB, Douglas RG Jr, Geiman JM, Meagher MP: Viral shedding patterns of children 
with influenza B infection. J Infect Dis 1979, 140(4):610–613. 
3. Frank AL, Taber LH, Wells CR, Wells JM, Glezen WP, Paredes A: Patterns of shedding 
of myxoviruses and paramyxoviruses in children. J Infect Dis 1981, 144(5):433–441. 
4. Fox JP, Hall CE, Cooney MK, Foy HM: Influenza virus infections in Seattle families, 
1975–1979. I. Study design, methods and the occurrence of infections by time and age. 
Am J Epidemiol 1982, 116(2):212–227. 
5. Sato M, Hosoya M, Kato K, Suzuki H: Viral shedding in children with influenza virus 
infections treated with neuraminidase inhibitors. Pediatr Infect Dis J 2005, 24(10):931–
932. 
6. Carrat F, Vergu E, Ferguson NM, Lemaitre M, Cauchemez S, Leach S, Valleron AJ: Time 
lines of infection and disease in human influenza: a review of volunteer challenge 
studies. Am J Epidemiol 2008, 167(7):775–785. 
7. Fraser C, Donnelly CA, Cauchemez S, Hanage WP, Van Kerkhove MD, Hollingsworth 
TD, Griffin J, Baggaley RF, Jenkins HE, Lyons EJ, Jombart T, Hinsley WR, Grassly NC, 
Balloux F, Ghani AC, Ferguson NM: Pandemic potential of a strain of influenza A 
(H1N1): early findings. Science 2009, 324(5934):1557–1561. 
8. Longini IM Jr, Halloran ME, Nizam A, Yang Y: Containing pandemic influenza with 
antiviral agents. Am J Epidemiol 2004, 159(7):623–633. 
9. Longini IM, Nizam A, Xu S, Ungchusak K, Hanshaoworakul W, Cummings DA, Halloran 
ME: Containing pandemic influenza at the source. Science 2005, 309(5737):1083–1087. 
10. Germann TC, Kadau K, Longini IM Jr, Macken CA, Affiliations A: From the cover: 
mitigation strategies for pandemic influenza in the United States. Proc Natl Acad Sci U S 
A 2006, 103(15):5935–5940. 
11. Hsu SB, Hsieh YH: On the role of asymptomatic infection in transmission dynamics 
of infectious diseases. Bull Math Biol 2008, 70(1):134–155. 
12. Longini IM Jr, Koopman JS, Monto AS, et al: Estimating household and community 
transmission parameters for influenza. Am J Epidemiol 1982, 115(5):736–751. 
13. Viboud C, Boelle PY, Cauchemez S, et al: Risk factors of influenza transmission in 
households. Br J Gen Pract 2004, 54(506):684–689. 
14. Cauchemez S, Carrat F, Viboud C, Valleron AJ, Boelle PY: Quantifying the role of 
children in influenza spread: an analysis of household follow-up. Int Congr Ser 2004, 
1263:288–290. 
15. Schanzer D, Vachon J, Pelletier L: Age-specific differences in influenza a epidemic 
curves: do children drive the spread of influenza epidemics? Am J Epidemiol 2011, 
174(1):109–117. 
16. Chao DY, Cheng KF, Hsieh YH, Li TC, Wu TN, Chen CY, Tsai CA, Chen JH, Lu JJ, Su 
MC, Liao YH, Chan WC: Serological response and persistence in schoolchildren with 
high baseline seropositive rate after receiving 2009 pandemic influenza A(H1N1) 
vaccine. Vaccine 2011, 29(4):617–623. 
17. Peacey M, Hall RJ, Sonnberg S, Ducatez M, Paine S, Nicol M, Ralston JC, 
Bandaranayake D, Hope V, Webby RJ, Huang S: Pandemic (H1N1) 2009 and seasonal A 
(H1N1) influenza co-infection, New Zealand, 2009. Emerg Infect Dis 2010, 16(10):1618–
1620. 
18. Cohen J: Vaccine policy. Immunizing kids against flumayprevent deaths among the 
elderly. Science 2004, 306(5699):1123. 
19. Bishop JF, Murnane MP, Owen R: Australia’s winter with the 2009 pandemic 
influenza A (H1N1) virus. N Engl J Med 2009, 361(27):2591–2594. 
20. Chao DY, Cheng KF, Li TC, WuTN CCY, Tsai CA, Chen JH, Lu JJ, Su MC, Liao YH, 
Chan WC, Hsieh YH: Serological evidence of subclinical transmission of the 2009 
pandemic H1N1 influenza virus outside of Mexico. PLos One 2011, 6(1):e14555. 
21. Carrat F, Tachet A, Rouzioux C, Housset B, Valleron AJ: Evaluation of clinical case 
definitions of influenza: detailed investigation of patients during the 1995–1996 
epidemic in France. Clin Infect Dis 1999, 28(2):283–290. 
22. Monto AS, Gravenstein S, Elliott M, Colopy M, Schweinle J: Clinical signs and 
symptoms predicting influenza infection. Arch Intern Med 2000, 160(21):3243–3247. 
23. Call SA, Vollenweider MA, Hornung CA, Simel DL, McKinney WP: Does this patient 
have influenza? JAMA 2005, 293(8):987–997. 
24. Ohmit SE, Monto AS: Symptomatic predictors of influenza virus positivity in 
children during the influenza season. Clin Infect Dis 2006, 43(5):564–568. 
25. US Centers for Disease Control and Prevention (CDC): Flu Symptoms & Severity. ; 
2013. US CDC website. Available: http://www.cdc.gov/flu/about/disease/symptoms.htm. 
Last accessed: September 24, 2013. 
26. Lin CY: Serological Surveillance of Human Influenza Viruses among Elementary 
Schoolchildren in Taiwan during the 2005–2006 Influenza Season. Taipei: Master thesis, 
National Taiwan University; 2007. 
27. Wang TE, Lin CY, King CC, Lee WC: Estimating pathogen-specific asymptomatic 
ratios. Epidemiology 2010, 21(5):726–728. 
28. Monto AS, Sullivan KM: Acute respiratory illness in the community: frequency of 
illness and the agents involved. Epidemiol Infect 1993, 110(1):145–160. 
29. Wang SF, Lee YM, Chan YJ, Liu HF, Yen YF, Liu WT, Huang JC, Chen YM: Influenza 
a virus in Taiwan, 1980–2006: phylogenetic and antigenic characteristics of the 
hemagglutinin gene. J Med Virol 2009, 81(8):1457–1470. 
30. Efron B, Hastie T, Johnstone I, Tibshirani R: Least angle regression. Ann Stat 2004, 
32(2):407–499. 
31. Li S, Leader S: Economic burden and absenteeism from influenza-like illness in 
healthy households with children (5–17 years) in the US. Respir Med 2007, 101(6):1244–
1250. 
32. Lloyd-Smith JO, Schreiber SJ, Kopp PE, Getz WM: Superspreading and the effect of 
individual variation on disease emergence. Nature 2005, 438(7066):355–359. 
33. Reichert TA, Sugaya N, Fedson DS, Glezen WP, Simonsen L, Tashiro M: The Japanese 
experience with vaccinating schoolchildren against influenza. N Engl J Med 2001, 
344(12):889–896. 
34. Glezen WP: Emerging infections: pandemic influenza. Epidemiol Rev 1996, 18(1):64–
76. 
